Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia

NCT02552303 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02552303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02552303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
July 31, 2015
Enrollment
39 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, sleep apnea